Successful Treatment of Common Variable Immunodeficiency Disorder-Associated Diarrhea With Budesonide: A Case Report

Elnachef, Najwa; McMorris, Marc; Chey, William D.
June 2007
American Journal of Gastroenterology;Jun2007, Vol. 102 Issue 6, p1322
Academic Journal
PURPOSE: Common variable immunodeficiency disorder (CVID) is an immunological disease that can present with gastrointestinal (GI) symptoms including chronic diarrhea and abdominal pain. We report a patient with CVID and chronic diarrhea who significantly improved with budesonide. METHODS: A 47-yr-old woman with CVID-associated diarrhea, steatorrhea, abdominal pain, and bloating for several years had an exhaustive evaluation for secondary causes of her symptoms, which was unrevealing. At the advice of her immunologist, she attempted a course with budesonide that significantly improved her GI symptoms. Given the absence of literature on this treatment in CVID, we attempted to systematically evaluate the clinical benefits after withdrawal of and retreatment with budesonide. RESULTS: Diarrhea, steatorrhea, abdominal pain, and bloating recurred within 2 days of discontinuing budesonide. All parameters assessed improved upon reinitiating budesonide. Further, serum immunoglobulin G (IgG) levels significantly increased with treatment. No significant side effects were observed with budesonide. CONCLUSION: This is the first report of a patient with CVID-related chronic diarrhea to be successfully treated with oral budesonide. This observation provides clinicians with an effective and safe treatment option in this difficult group of patients.


Related Articles

  • Atopic dermatitis. Watson, Wade; Kapur, Sandeep // Allergy, Asthma & Clinical Immunology;2011 Supplement 1, Vol. 7 Issue S1, p1 

    Atopic dermatitis (AD) is a common, chronic skin disorder that can significantly impact the quality of life of affected individuals as well as their families. Although the pathogenesis of the disorder is not completely understood, it appears to result from the complex interplay between defects...

  • Treat gout with anti-inflammatories and urate-lowering therapies, unless such treatment is ineffective or inappropriate.  // Drugs & Therapy Perspectives;Jun2012, Vol. 28 Issue 6, p15 

    Gout is caused by chronic hyperuricaemia and the formation of pro-inflammatory monosodium urate crystals in the joints. Pain associated with acute gout flares is treated with anti-inflammatories (e.g. NSAIDs, colchicine and corticosteroids). Chronic gout is managed with urate-lowering therapies...

  • Preventing glucocorticoid-induced osteoporosis. Zarek, Deborah T.; Katz, James D.; Diloreto, Stacy // Patient Care;Sep2002, Vol. 36 Issue 11, p64 

    Provides information on how to prevent glucocorticoid-induced osteoporosis (GIO). Details of how glucocorticoids cause bone loss; Strategies for the prevention and treatment of GIO; Evidence of underutilization of preventive therapy against GIO.

  • Revitalising glucocorticoids for (rheumatoid) arthritis. Kirwan, John R. // Clinical Medicine;Apr2010, Vol. 10 Issue 2, p159 

    The article discusses the potential of glucocorticoids on the disease process in rheumatoid arthritis (RA). From 1995 to 2010, evidence has revealed that glucocorticoids can halt the destructive changes of RA and can control the overall clinical picture as effectively as modern anti-tumour...

  • Do Glucocorticoids Have Adverse Effects on Brain Function? Keenan, P.A.; Kuhn, T.W. // CNS Drugs;1999, Vol. 11 Issue 4, p245 

    Glucocorticoids, a class of steroid hormones, can adversely affect the brain, particularly the hippocampus. The effect is most likely to be indirect and in response to either endogenously or exogenously induced hypercortisolaemia. While the stress response is clearly adaptive and therapeutic...

  • Failure-to-Thrive in an Infant Following Injection of Capillary Hemangioma With Triamcinolone Acetonide. DeBoer, Mark D.; Boston, Bruce A. // Clinical Pediatrics;Apr2008, Vol. 47 Issue 3, p296 

    The article investigates the benefits, risks and side effects of triamcinolone acetonide (TCA) treatment among children with capillary hemangioma in the U.S. Many surgeons are aware of the complications on the removal of capillary hemangiomas so they prefer intralesional injections using...

  • Depigmentation — a rare side effect to intra-articular glucocorticoid treatment. Rogojan, Cornelia; Hetland, Merete Lund // Clinical Rheumatology;Aug2004, Vol. 23 Issue 4, p373 

    Intra-articular glucocorticoid injections are often used in patients with rheumatoid arthritis, either as bridging therapy or in periods with increased disease activity. We present a case of local skin depigmentation that occurred at the site of injection in a dark-skinned patient....

  • Adrenal Suppression After Glucocorticoid Therapy. Walling, Anne D. // American Family Physician;7/15/2000, Vol. 62 Issue 2, p442 

    Presents information on a study by C. Henzen and others to evaluate the frequency of adrenal suppression in patients following a short course of high-dose glucocorticoid therapy. Description of the study and its results; Conclusion that adrenal function is commonly suppressed immediately...

  • Hemophagocytic syndrome in adult-onset Still's disease (AOSD): A must for biologics?-Case report and brief review of the literature. Bürgi, Urs; Mendez, Adriana; Hasler, Paul; Hüllstrung, Hans // Rheumatology International;Oct2012, Vol. 32 Issue 10, p3269 

    A case of adult-onset Still's disease complicated by hemophagocytic lymphohistiocytosis is reported. Its management is being discussed on the background of the latest literature with special regard on the use of high-dose corticosteroids and immunosuppressive agents.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics